Heroin use impairs smoking cessation among Australian prisoners

BMC Public Health

Kay A Wilhelm¹  Vicki A Archer²  Tony G Butler³  Robyn L Richmond⁵  Alex D Wodak⁴  Devon Indig⁵ 

[1] School of Psychiatry, University of New South Wales, Sydney, NSW 2052, Australia;Justice & Forensic Mental Health Network, Centre for Health Research in Criminal Justice, Suite 302, Level 2, 152 Bunnerong Road, Pagewood, NSW 2035, Australia;Kirby Institute, University of New South Wales, Sydney, NSW 2052, Australia;Alcohol and Drug Service, St Vincent’s Hospital, 390 Victoria Street, Sydney, NSW 2010, Australia;School of Public Health and Community Medicine, University of New South Wales, Sydney, NSW 2052, Australia

关键词: Nicotine dependence;    Smoking cessation;    Prisoner;    Heroin;   

Others  :  1161424
DOI  :  10.1186/1471-2458-13-1200

 received in 2013-07-03, accepted in 2013-12-09,  发布年份 2013

【 摘 要 】

Background

Prisoners have extremely high rates of smoking with rates 3–4 times higher than the general community. Many prisoners have used heroin. The aims of this study were to investigate the impact of heroin use on smoking cessation and the social determinants of health among prisoners.

Methods

Secondary analysis of data from a randomised controlled trial of a multi-component smoking cessation intervention involving 425 Australian male prisoners. Inmates who, prior to imprisonment, used heroin regularly were compared to those who did not use heroin regularly. Self-reported smoking status was validated at baseline and each follow-up by measuring carbon monoxide levels. Readings exceeding 10 ppm were defined as indicating current smoking.

Results

Over half (56.5%) of the participants had ever used heroin while 37.7% regularly (daily or almost daily) used heroin in the year prior to entering prison. Prisoners who regularly used heroin had significantly worse social determinants of health and smoking behaviours, including lower educational attainment, more frequent incarceration and earlier initiation into smoking. Prisoners who regularly used heroin also used and injected other drugs significantly more frequently. At 12-month follow-up, the smoking cessation of prisoners who had regularly used heroin was also significantly lower than prisoners who did not regularly use heroin, a finding confirmed by logistic regression.

Conclusions

Regular heroin use prior to imprisonment is an important risk factor for unsuccessful attempts to quit smoking among prisoners and is also associated with worse social determinants of health, higher drug use, and worse smoking behaviours. More effective and earlier smoking cessation interventions are required for particularly disadvantaged groups.

Trial registration

This trial is registered with the Australian New Zealand Clinical Trials Registry 12606000229572.

【 授权许可】

   
2013 Indig et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Australian Institute of Health and Welfare: 2010 National Drug Strategy Household Survey Report. Drug Statistics Series No. 25. Canberra: Australian Institute of Health and Welfare; 2011.
• [2]Woodward SD: Trends in cigarette consumption in Australia. Aust N Z J Med 1984, 14:405-407.
• [3]Richmond RL, Butler T, Belcher JM, Wodak A, Wilhelm KA, Baxter E: Promoting smoking cessation among prisoners: feasibility of a multi-component intervention. Aust NZ J Public Health 2006, 30:474-478.
• [4]Richter KP, Ahluwalia HKA, Mosier MC, Nazir N, Ahluwalla JS: A population-based study of cigarette smoking among illicit drug users in the United States. Addiction 2002, 97:861-869.
• [5]Baker A, Ivers R, Bowman J, Butler T, Kay-Lambkin FJ, Wye P, et al.: Where there’s smoke, there’s fire: High prevalence of smoking among some sub-populations. Drug Alcohol Rev 2006, 25:85-96.
• [6]Indig D, Topp L, Ross B, Mamoon H, Border B, Kumar S, et al.: 2009 NSW Inmate Health Survey: Key Findings Report. Sydney: Justice Health; 2010.
• [7]Butler T, Lim D, Callander D: National Prison Entrants’ Bloodborne Virus and Risk Behaviour Survey Report 2004, 2007 & 2010. Sydney: Kirby Institute (University of New South Wales) and National Drug Research Institute (Curtin University); 2011.
• [8]Cropsey K, Eldridge GD, Ladner T: Smoking among female prisoners: an ignored public health epidemic. Addict Behav 2004, 29:425-431.
• [9]Clarke JG, Stein MD, McGarry KA, Gogineni A: Interest in smoking cessation among injection drug users. Am J Addiction 2001, 10:159-166.
• [10]United Nations Office on Drugs and Crime: World Drug Report 2012. United Nations Publication, Sales No. E.12.X1.1. New York: United Nations Office on Drugs and Crime; 2012.
• [11]Australian Institute of Health and Welfare: The health of Australia’s prisoners 2009. AIHW Cat. No. PHE 123. Canberra: Australian Institute of Health and Welfare; 2010.
• [12]Wodak A: What caused the recent reduction in heroin supply in Australia. Int J Drug Pol 2008, 19:279-286.
• [13]Degenhardt L, Day C, Dietze P, Pointer S, Conroy E, Collins L, et al.: Effects of a sustained heroin shortage in three Australian states. Addiction 2005, 100:908-920.
• [14]Bowman J, Wiggers J, Colyvas K, Wye P, Walsh RA, Bartlem K: Smoking cessation among Australian methadone clients: prevalence, characteristics and a need for action. Drug Alcohol Rev 2012, 31:507-513.
• [15]Pajusco B, Chiamulera C, Quaglio G, Moro L, Casari R, Amen G, et al.: Tobacco addiction and smoking status in heroin addicts under methadone vs. buprenorphine therapy. Int J Environ Res Publ Heal 2012, 9:932-942.
• [16]McCool RM, Richter KP: Why do so many drug users smoke? J Subst Abuse Treat 2003, 25:43-49.
• [17]Sullivan MA, Covey LS: Current perspectives on smoking cessation among substance abusers. Curr Psych Rep 2002, 4:388-396.
• [18]Clemmey P, Brooner R, Chutuape MA, Kidorf M, Stitzer M: Smoking habits and attitudes in a methadone maintenance treatment population. Drug Alcohol Dep 1997, 44:123-132.
• [19]Richter KP, Gibson CA, Ahluwalia JS, Schmelzle KH: Tobacco use and quit attempts among methadone maintenance clients. Am J Public Health 2001, 91:296-299.
• [20]Richmond R, Indig D, Butler T, Wilhelm K, Archer V, Wodak A: A randomised controlled trial of a smoking cessation intervention conducted among prisoners. Addiction 2013, 108:966-974.
• [21]Corben S: NSW inmate census 2011: summary of characteristics. Statistical publication no. 38. Corrective Services NSW: Sydney; 2011.
• [22]Heatherton T, Kozlowski L, Frecker R, Fagerström K: The fagerström test for nicotine dependence: a revision of the fagerström tolerance questionnaire. Brit J Addict 1991, 86:1119-1127.
• [23]Wright CC, Sim J: Intention to treat approach to data from randomised controlled trials: a sensitivity analysis. J Clin Epidemiol 2003, 56:833-842.
• [24]Cropsey K, Eldridge GD, Weaver MF, Villabos GC, Stitzer ML: Expired carbon monoxide levels in self-reported smokers and non-smokers in prison. Nicotine Tob Res 2006, 8:652-659.
• [25]SAS Institute: The SAS System for Windows version 9.2. Cary, North Carolina: SAS Institute Inc.; 2007.
• [26]Richter KP, Ahluwalia JS: A case for addressing cigarette use in methadone and opioid treatment programs. J Addict Dis 2000, 19:35-52.
• [27]Hall SM, Prochaska JJ: Treatment of smokers with co-occuring disorders: Emphasis on integration in mental health and addiction treatment settings. Annu Rev Clin Psychol 2009, 5:409-431.
• [28]Ezzati M, Lopez AD: Estimates of global mortality attributable to smoking in 2000. Lancet 2003, 362:847-852.
• [29]Oppenheimer E, Tobutt C, Taylor C, Andrew T: Death and survival in a cohort of heroin addicts from London clinics: a 22-year follow-up study. Addiction 1994, 89:1299-1308.
• [30]Prochaska JJ, Spring B, Nigg CR: Multiple behaviour change research: an introduction and overview. Prev Med 2008, 46:181-188.
• [31]Goldstein MG, Whitlock EP, DePue J: Multiple behavioural risk factor interventions in primary care. Summary of research evidence. Am J Prev Med 2004, 27:61-79.
• [32]Prochaska JJ, Delucchi K, Hall SM: A meta-analysis of smoking cessation interventions with individuals in substance abuse treatment or recovery. J Consult Clin Psych 2004, 72:1144-1156.
• [33]Kalman D: Smoking cessation treatment for substance misusers in early recovery: a review of the literature. Subst Use Misuse 1998, 33:2021-2047.
• [34]Lemon SC, Friedmann PD, Stein MD: The impact of smoking cessation on drug abuse treatment outcome. Addict Behav 2003, 28:1323-1331.
• [35]Hall W, Doran C, Degenhardt L, Shepard D: Illicit opiate abuse. In Disease Control Priorities in Developing Countries. 2nd edition. Edited by Jamison DT, Breman JG, Measham AR, Alleyne G, Claeson M, Evans DB, Jha P, Mills A, Musgrove P. Washington (DC): World Bank; 2006. Chapter 48
• [36]Flint AJ, Novotny TE: Poverty status and cigarette smoking prevalence and cessation in the United States, 1983–1993: the independent risk of being poor. Tob Control 1997, 6:14-18.
• [37]Gilman SE, Abrams DB, Buka SL: Socioeconomic status over the life course and stages of cigarette use: initiation, regular use and cessation. J Epidemiol Commun H 2003, 57:802-808.
• [38]World Health Organisation: Social determinants of health: the solid facts. In Second edition. Edited by Richard W, Michael M. Denmark: World Health Organisation; 2003.
• [39]Knudsen HK, Studts JL, Boyd S, Roman PM: Structural and cultural barriers to the adoption of smoking cessation services in addiction treatment organisations. J Addict Dis 2010, 29:294-305.
• [40]Schroeder SA, Morris CD: Confronting a neglected epidemic: tobacco cessation for persons with mental illnesses and substance abuse problems. Annu Rev Publ Health 2010, 31:297-314.
• [41]Ziedonis DM, Guydish J, Williams JM, Steinberg M, Foulds J: Barriers and solutions to addressing tobacco dependence in addiction treatment programs. Alcohol Res Health 2006, 29:228-235.
• [42]Guydish J, Passalacqua E, Tajima B, Manser ST: Staff smoking and other barriers to nicotine dependence intervention in addiction treatment settings: a review. J Psycho Drugs 2007, 39:423-433.
• [43]Buchman DZ, Skinner W, Illes J: Negotiating the relationship between addiction, ethics and brain science. AJOB Neurosci 2010, 1:36-45.